Tag: IntelGenx - Psychedelic Alpha

Access exclusive insights, data and interviews with Pα+: learn more and subscribe today.

IntelGenx Announces Initial Closing of atai Investment

Post published:May 14, 2021
Post category:Press Release

Read more about the article IntelGenx Expands Psychedelics Collaboration with atai Life Sciences with Signing of Second Feasibility Agreement

IntelGenx Expands Psychedelics Collaboration with atai Life Sciences with Signing of Second Feasibility Agreement

Post published:May 12, 2021
Post category:Press Release

IntelGenx Announces Shareholder Approval of atai Investment

Post published:May 11, 2021
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Insights
Jobs
Data
Subscribe to Pα+
Contact

Insights and interviews delivered to your inbox. No spam, just valuable information.

IntelGenx Announces Initial Closing of atai Investment

IntelGenx Expands Psychedelics Collaboration with atai Life Sciences with Signing of Second Feasibility Agreement

IntelGenx Announces Shareholder Approval of atai Investment

Psychedelic Alpha

Quick Links

Newsletter

Subscribe to Our Free Newsletter

Join Pα+ for Premium Insights